1. Al-Brahim NYY, Asa SL. My approach to pathology of the pituitary gland. J Clin Pathol 2006; 59:1245-1253.
2. Surawicz TS, McCarthy BJ, Kupelian V, Jukich PJ, Bruner JM, Davis FG. Descriptive epidemiology of primary brain and CNS tumors: Results from the Central Brain Tumor Registry of the United States, 1990-1994. Neuro-Oncology 1999; 1:14-25.
3. Nilsson B, Gustavsson-Kadaka E, Bengtsson B, Jonsson B. Pituitary adenomas in Sweden between 1958 and 1991; Incidence, survival and mortality. J Clin Endocrinology and Metabolism 2000; 85(4):1420-1425.
4. Asa SL, Ezzat S. The pathogenesis of pituitary tumours. Nature Reviews 2002; 2:836-849.
5. Mindermann T, Wilson CB. Age-related and gender-related occurrence of pituitary adenomas. Clin Endocrinol 1994; 41:359-364.
6. Ezzat S, Asa SL, Couldwell WT et al. The prevalence of pituitary adenomas. Cancer 2004; 101(3):613-619.
7. Daly AF, Rixhon M, Adam C, Dempegioti A, Tichimirowa MA, Beckers A. High prevalence of pituitary adenomas: A cross-sectional study in the province of Liege, Belgium. J Clin Endocrinol Metab 2006; 91(12):4769-4775.
8. Nielsen EH, Lindholm J, Laurberg P et al. Nonfunctioning pituitary adenoma: incidence, causes of death and quality of life in relation to pituitary function. Pituitary 2007; 1(1):1-2.
9. Clayton RN. Sporadic pituitary tumours: from epidemiology to use of databases. Baillieres Clin Endocrinol Metab 1999; 13(3):451-460.
10. Melmed S. Acromegaly. N Engl J Med 2006; 355:2558-2573.
11. Arafah BM. Reversible hypopituitarism in patients with large nonfunctioning pituitary adenomas. J Clin Endocrinol Metab 1986; 62:1173-1179.
12. Webb SM, Rigla M, Wägner A, Oliver B, Bartumeus F. Recovery of hypopituitarism after neurosurgical treatment of pituitary adenomas. J Clin Endocrinology and Metabolism 1999; 84(10):3696-3700.
13. Brada M, Rajan B, Traish D et al. The long-term efficacy of conservative surgery and radiotherapy in the control of pituitary adenomas. Clin Endocrinol 1993; 38:571-578.
14. Rajasoorya C, Holdaway IM, Wrightson P, Scott DT, Ibbertson HK. Determinants of clinical outcome and survival in acromegaly. Clin Endocrinol 1994; 41:95-102.
15. Alexander L, Appleton D, Hall R, Ross WM, Wilkinson R. Epidemiology of acromegaly in the Newcastle region. Clin Endocrinol 1980; 12:71-79.
16. Mahmoud-Ahmed AS, Suh JH. Radiation Therapy for Cushing’Disease: A Review. Pituitary 2002; 5:175-180.
17. Molitch ME, Russell EJ. The pituitary ïncidentaloma”. Ann Intern Med 1990; 112(12):925-931.
18. Hall WA, Luciano MG, Doppman JL, Patronas NJ, Oldfield EH. Pituitary magnetic resonance imaging in normal human volunteers: occult adenomas in the general population. Ann Intern Med 1994; 120(10):817-820.
19. King JT, Justice AC, Aron DC. Management of incidental pituitary microadenomas; A cost-effectiveness analysis. J Clin Endocrinol Metab 1997; 82(11):3625-2632.
20. Sassolas G, Trouillas J, Trluyer C, Perrin G. Management of nonfunctioning pituitary adenomas. Acta Endocrinol (Copenh ) 1993; 129(Suppl.):121-126.
21. Monson JP. Is there still a role for radiotherapy in acromegaly? Neuroendocrinology 2006; 83:269-273.
22. Frohman LA, Bonert V. Pituitary tumor enlargement in two patients with acromegaly during pegvisomant. Pituitary 2007; 10(3):283-289.
23. Erlichman C, Meakin JW, Simpson WJ. Review of 154 patients with non-functioning pituitary tumors. Int J Radiat Oncol Biol Phys 1979; 5:1981-1986.
24. Rauhut F, Stuschke M, Sack H, Stolke D. Volume dependence of late effects after radiotherapy of invasive pituitary adenomas. In: Wiegel T, Hinkelbein W, Brock M, Hoell T, editors. Controversies in Neuro-oncology. Front Radiat Ther Oncol. 1 ed. Basel: Karger; 1999 p. 315-317.
25. Meij BJ, Lopes M-BS, Ellegala DB, Alden TD, Laws ER. The long-term significance of microscopic dural invasion in 354 patients with pituitary adenomas treated with transsphenoidal surgery. J Neurosurg 2002; 96:195-208.
26. Soto-Ares G, Cortet-Rudelli C, Assaker R et al. MRI protocol technique in the optimal therapeutic strategy of non-functioning pituitary adenomas. Eur J Endocrinol. 2002; 146(2): 283-289.
27. Turner HE, Stratton IM, Byrne JV, Adams CBT, Wass JAH. Audit of selected patients with nonfunctioning pituitary adenomas treated without irradiation – a follow-up study. Clin Endocrinol 1999; 51:281-284.
28. Ludecke DK, Abe T. Transsphenoidal microsurgery for newly diagnosed acromegaly:
a personal view after more than 1000 operations. Neuroendocrinology 2006; 83:230-239.
29. Cappabianca P, Decq P, Schroeder HWS. Future of endoscopy in neurosurgery. Surg Neurol 2007; 67:496-498.
30. Bergh van den ACM, Berg van den G, Schoorl MA et al. Immediate postoperative radiotherapy in residual nonfunctioning pituitary adenoma; beneficial effect on local control without additional negative impact on pituitary function and life expectancy. Int J Rad Oncol Biol Phys 2007; 68(4):986-991
31. Fahlbusch R, Keller Bv, Ganslandt O, Kreutzer J, Nimsky C. Transsphenoidal surgery in acromegaly investigated by intraoperative high-field magnetic resonance imaging. Eur J Endocrinol 2005; 153:239-248.
32. Berg G v, Dulken H v, Frolich M, Meinders AE, Roelfsema F. Can intra-operative Gh measurement in acromegalic subjects predict completeness of surgery? Clin Endocrinol 1998; 49(1):45-51.
33. Nieman L, Ilias I. Evaluation and treatment of Cushing’s syndrome. Am J Med 2005; 118:1340-1346.
34. Aken van MO, Lely van der AJ, Romijn JA, Lamberts SWJ, Herder de WW. Syndroom van Cushing. Nieuwe behandelingen. Ned Tijdschr Geneeskd 2006; 150:2365-2369.
35. Greenman Y, Tordjman K, Kisch E, Razon N, Ouanine G, Stern N. Relative sparing of anterior pituitary function in patients with growth hormone-secreting macro-adenomas: comparison with nonfunctioning macroadenomas. J Clin Endocrinology and Metabolism 1995; 80:1577-1583.
36. Comtois R, Beauregard H, Somma M, Serri O, Aris-Jilwan N, Hardy J. The clinical and endocrine outcome to transsphenoidal microsurgery of nonsecreting pituitary adenomas. Cancer 1991; 68:860-866.
37. Marazuela M, Astigarraga B, Vicente A. Recovery of visual and endocrine function following transsphenoidal surgery of large non-functioning pituitary adenomas. Journal Endocrinol Invest 1994; 17:703-707.
38. Ebersold MJ, Quast LM, Laws ER, Scheithauer B, Randall RV. Long-term results in transsphenoidal removal of nonfunctioning pituitary adenomas. J Neurosurg 1986; 64:713-719.
39. Oruckaptan HK, Senmevsim O, Ozcan OE, Ozgen T. Pituitary adenomas: Results of 684 surgically treated patients and review of the literature. Surg Neurol 2000; 53:211-219.
40. Gramegna A. Un cas d’acromégalie traité par la radiothérapie. Rev Neurol 1909; 17:15-17.
41. Chang CH, Pool JL. The radiotherapy of pituitary chromophobe adenomas. Radiology 1967; 89(6):1005-1016.
42. Parrott J, Mullins ME. Postoperative imaging of the pituitary gland. Top Magn Reson Imaging 2005; 16:317-323.
43. McCollough WM, Marcus RB, Rhoton AL, Ballinger WE, Million RR. Long-term follow-up of radiotherapy for pituitary adenoma: the absence of late recurrence after >4500cGy. Int J Radiat Oncol Biol Phys 1991; 21:607-614.
44. Tsao MN, Wara WM, Larson D. Radiation therapy for benign central nervous system disease. Semin Radiat Oncol 1999; 9:120-133.
45. Perks JR, Jalali R, Cosgrove VP et al. Optimization of stereotactically-guided conformal treatment planning of sellar and parasellar tumors, based on normal brain dose volume histograms. Int J Radiat Oncol Biol Phys 1999; 45(2):507-513.
46. Estrada J, Boronat M, Mielgo M et al. The Long-Term Outcome of Pituitary Irradiation after Unsuccessful Transsphenoidal Surgery in Cushing’s Disease. The New England Journal of Medicine 1997; 336(3):172-177.
47. Zaugg M, Adaman O, Pescia R, Landolt AM. External irradiation of macroinvasive pituitary adenomas with telecobalt: a retrospective study with long-term follow-up in patients irradiated with doses mostly of between 40-50 Gy. Int J Radiat Oncol Biol Phys 1995; 32(3):671-680.
48. Salinger DJ, Brady LW, Miyamoto CT. Radiation therapy in the treatment of pituitary adenomas. Am J Clin Oncol 1992; 15(6):467-473.
49. Cornett MS, Paris KJ, Spanos WJ, Lindberg RD, Jose B. Radiation therapy for pituitary adenomas. Am J Clin Oncol 1996; 19(3):292-295.
50. Rush S, Cooper PR. Symptom resolution, tumor control, and side effects following postoperative radiotherapy for pituitary macroadenomas. Int J Radiat Oncol Biol Phys 1997; 5:1031-1034.
51. Halberg F, Sheline GE. Radiotherapy of pituitary tumors. Endocrinology and metabolism clinics 1987; 16(3):667-684.
52. Jalali R, Brada M, Perks JR et al. Stereotactic conformal radiotherapy for pituitary adenomas: technique and preliminary experience. Clin Endocrinol 2000; 52:695-702.
53. Hughes MN, Llamas KJ, Yelland ME, Obst D, Tripcony LB. Pituitary adenomas: long-term results for radiotherapy alone and post-operative radiotherapy. Int J Radiat Oncol Biol Phys 1993; 27(5):1035-1043.
54. Snyder PJ, Fowble BF, Schatz NJ, Savino PJ, Gennarelli TA. Hypopituitarism following radiation therapy of pituitary adenomas. Am J Med 1986; 81(3):457-462.
55. Boelaert K, Gittoes NJL. Radiotherapy for non-functioning pituitary adenomas. Eur J Endocrinol 2001; 144:569-575.
56. Littley MD, Shalet SM, Beardwell CG, Ahmed SR, Applegate G, Sutton ML. Hypopituitarism following external radiotherapy for pituitary tumors in adults. Q J Med 1989; 70:145-160.
57. Tsang R, Brierley J, Panzarella T, Gospodarowicz M, Sutcliffe S, Simpson WJ. Radiation therapy for pituitary adenoma: Treatment outcome and prognostic factors. Int J Radiat Oncol Biol Phys 2001; 30(3):557-565.
58. Nelson PB, Goodman ML, Flickinger JC, Richardson DW, Robinson AG. Endocrine function in patients with large pituitary tumors treated with operative decompression and radiation therapy. Neurosurgery 1989; 24(3):398-400.
59. Agha A, Sherlock M, Brennan S et al. Hypothalamic-pituitary dysfunction after irradiation of nonpituitary brain tumors in adults. J Clin Endocrinol Metab 2005; 90(12):6355-6360.
60. Toogood AA. Endocrine consequences of brain irradiation. Growth Hormone IGF Research 2004; 14:S118-S124.
61. Littley MD, Shalet SM, Beardwell CG, Robinson EL, Sutton ML. Radiation-induced hypopituitarism is dose-dependent. Clin Endocrinol 1989; 31:363-373.
62. OHalloran DJ, Shalet SM. Radiotherapy for pituitary adenomas: An endocrinologist’s perspective. Clinical Oncology 1996; 8:79-84.
63. Lissett CA, Shalet SM. Management of pituitary tumours: Strategy for investigation and follow-up. Horm Res 2000; 53(suppl 3):65-70.
64. Satoh E, Imai A, Furui T. Successful pregnancy in a woman with acquired hypogonadism after treament with radiotherapy for cranial tumour. J Obstet Gynecol 2005; 25(5):523-525.
65. Vance ML. Treatment of patients with a pituitary adenoma: one clinician’s experience. Neurosurg Focus 2004; 16(4):1-6.
66. Flickinger JC, Nelson PB, Taylor F, Robinson A. Incidence of cerebral infarction after radiotherapy for pituitary adenoma. Cancer 1989; 63:2404-2408.
67. Erfurth E, Hagmar L. Cerebrovascular disease in patients with pituitary tumors. Trends in Endocrinology and Metabolism 2005; 16(7):334-342.
68. Brada M, Ashley S, Bliss JM et al. Risk of second brain tumour after conservative surgery and radiotherapy for pituitary adenoma. British Medical Journal 1992; 304:1343-1346.
69. Minniti G, Traish d, Ashley S, Gonsalves A, Brada M. Risk of second brain tumour after conservative surgery and radiotherapy for pituitary adenoma: update after further 10 years. J Clin Endocrinol Metab 2004.
70. Erfurth E, Bulow B, Mikoczy Z, Svahn-Tapper G, Hagmar L. Is there an increase in second brain tumours after surgery and irradiation for a pituitary tumour? Clin Endocrinol 2001; 55:613-616.
71. Jones A. Radiation oncogenesis in relation to the treatment of pituitary tumours. Clin Endocrinol 1991; 35:379-397.
72. Al-Mefty O, Kersh JE, Routh A, Smith RR. The long-term side effects of radiation therapy for benign brain tumors in adults. J Neurosurg 1990; 73:502-512.
73. Popovic V, Damjanovic S, Micic D et al. Increased incidence of neoplasia in patients with pituitary adenomas. Clin Endocrinol 1998; 49:441-445.
74. Brada M, Ashley S, Ford D, Traish d, Burchell L, Rajan B. Cerebrovascular mortality in patients with pituitary adenoma. Clin Endocrinol 2002; 57:713-717.
75. Becker G, Kocher M, Kortmann R-D et al. Radiation therapy in the multimodal treatment approach of pituitary adenoma. Strahlenther Onkol 2002; 4:173-186.
76. Bergh van den ACM, Schoorl MA, Dullaart RP et al. Lack of Radiation Optic Neuropathy in 72 patients treated for pituitary adenoma. J Neuroophthalmol 2004; 24(3):200-205.
77. Grattan-Smith PJ, Morris JG, Langlands AO. Delayed radiation necrosis of the central nervous system in patients irradiated for pituitary tumours. J Neurol Neurosurg Psychiatry 1992; 55:949-955.
78. Noad R, Narayanan KR, Howlett T, Lincoln NB, Page RCL. Evaluation of the effect of radiotherapy for pituitary tumours on cognitive function and quality of life. Clinical Oncology 2004; 16:233-237.
79. Mitsumori M, Shrieve DC, Alexander E et al. Initial clinical results of linac-based stereotactic radiosurgery and stereotactic radiotherapy for pituitary adenomas. Int J Radiat Oncol Biol Phys 1998; 42(3):573-580.
80. Yazlovitskaya EM, Edwards E, Thotala D et al. Lithium treatment prevents neurocognitive deficit resulting from cranial irradiation. Cancer Res 2006; 66(23):11179-11186.
81. Peace KA, Orme SM, Padayatty SJ, Godfrey HPD, Belchetz PE. Cognitive dysfunction in patients with pituitary tumour who have been treated with transfrontal or transsphenoidal surgery or medication. 1998; 49:391-396.
82. Johnson MD, Woodburn CJ, Vance ML. Quality of Life in patients with a pituitary adenoma. Pituitary 2003; 6:81-87.
83. Page RCL, Hammersley MS, Burke CW, Wass JAH. An account on the quality of life of patients after treatment for non-functioning pituitary tumours. Clin Endocrinol 1997; 46:401-406.